M
MaxQ Medical
Automated ultrasound imaging and HIFU therapy system.
About MaxQ Medical
MaxQ Medical, Inc. is a health-tech company based in Sunnyvale, California, operating in the urology sector. The firm is the first spinout from Orchard Ultrasound Innovation, an incubator that commercializes breakthrough ultrasound technology developed at Stanford University by Professor Pierre Khuri-Yakub, inventor of the Capacitive Micromachined Ultrasonic Transducer (CMUT). This foundation in decades of semiconductor ultrasound research provides a significant scientific basis for its technology platform. Led by CEO Amir Tehrani and Executive Chairman Amir Abolfathi, the company is developing a next-generation platform for prostate care. In August 2026, MaxQ Medical announced the closing of a $31.5 million Series A financing round. The round was led by prominent investors including Atlantic Blue Ventures, S3 Ventures, and Olympus Innovation Ventures, the venture arm of global endoscopy player Olympus. The capital is allocated to expanding the team and advancing the company's ongoing clinical programs. The company’s core product is an all-in-one, transurethral system that combines advanced ultrasound imaging with targeted High-Intensity Focused Ultrasound (HIFU) therapy. This platform is designed to be a fully automated, outpatient procedure that gives urologists direct visibility inside the prostate and the ability to treat the targeted tissue in a single session. A key design feature is its urethra-preserving capability, which aims to minimize common side effects associated with traditional treatments, such as injury, bleeding, and impact on sexual function. MaxQ Medical's strategy is to offer a solution that provides the durability of gold-standard resective therapies while maintaining a side-effect profile comparable to less invasive techniques. The initial target market is the treatment of benign prostatic hyperplasia (BPH), a condition affecting an estimated 40 million men in the U.S. The company has long-term plans to expand its platform's application to include focal therapy for prostate cancer and broader diagnostics like biopsies and tumor mapping. The MaxQ system is currently investigational and is not yet available for commercial use in the United States.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2023
- Headquarters
- Sunnyvale, United States
- Open positions
- None listed
- Dealroom signal
- 20.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Radiology, Medical Imaging, Non-Invasive medical devices and treatments
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2026 | $32M | $126M | Olympus Innovation Ventures · Highside Capital Management · S3 Ventures | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Medicana Health Group I United KingdomPrivate clinic for diagnostics and multidisciplinary specialty care. |
Winchester, United Kingdom | Operational | 28 | — | — |
SonaScience-backed music for sleep, stress, and anxiety |
United Kingdom | Operational | |||
MRI FirstCost-effective diagnostics via proprietary Fast MRI protocols. |
United States | Operational | |||
Concordia StrategyHealth Tech & Medtech |
Melbourne, Australia | Operational | |||
Luxe Medical ImagingPremium diagnostic and preventative medical imaging services. |
Fayetteville, United States | Operational | |||
OrbisOne Medical SpAAI-powered handheld ultrasound for point-of-care diagnostics. |
Chile | Operational | |||
BravoImagingAI-powered medical imaging diagnostics for clinical workflow. |
— | Operational | |||
JeevniAIAI-powered quality assessment for medical imaging. |
New Delhi, India | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MaxQ Medical in the Sunnyvale ecosystem
The MaxQ Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Olympus Innovation Ventures
S3 Ventures
Highside Capital Management
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MaxQ Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MaxQ Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








